RESEARCH-USE BIOSIMILAR ANTIBODY

Tozorakimab

Monoclonal antibody · IgG1

IL33IgG1RUO

Tozorakimab (MEDI-3506) is a human immunoglobulin G1 monoclonal antibody targeting interleukin-33. Tozorakimab reduces inflammation and epithelial dysfunction. Tozorakimab can be used to research chronic obstructive pulmonary disease.

TARGETIL33
YMonoclonal antibody
CATALOGSC-BS-099
CATALOG NUMBERSC-BS-099
MOLECULAR WEIGHTApprox. 144.66 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Tozorakimab (MEDI-3506) is a human immunoglobulin G1 monoclonal antibody targeting interleukin-33. Tozorakimab reduces inflammation and epithelial dysfunction. Tozorakimab can be used to research chronic obstructive pulmonary disease.

Tozorakimab is a recombinant research-use antibody directed against IL33.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Tozorakimab | StellaCyte